rs10776910

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000093.5(COL5A1):​c.4176+35A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.42 in 1,593,238 control chromosomes in the GnomAD database, including 143,903 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.47 ( 17317 hom., cov: 33)
Exomes 𝑓: 0.42 ( 126586 hom. )

Consequence

COL5A1
NM_000093.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -3.10

Publications

9 publications found
Variant links:
Genes affected
COL5A1 (HGNC:2209): (collagen type V alpha 1 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. The encoded procollagen protein occurs commonly as the heterotrimer pro-alpha1(V)-pro-alpha1(V)-pro-alpha2(V). Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
COL5A1 Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome, classic type
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, PanelApp Australia, Genomics England PanelApp
  • Ehlers-Danlos syndrome, classic type, 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • arterial disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 9-134817114-A-C is Benign according to our data. Variant chr9-134817114-A-C is described in ClinVar as Benign. ClinVar VariationId is 255085.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.616 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL5A1NM_000093.5 linkc.4176+35A>C intron_variant Intron 53 of 65 ENST00000371817.8 NP_000084.3 P20908-1A0A024R8E5B2ZZ86Q59EE7
COL5A1NM_001278074.1 linkc.4176+35A>C intron_variant Intron 53 of 65 NP_001265003.1 B2ZZ86Q59EE7
COL5A1XM_017014266.3 linkc.4176+35A>C intron_variant Intron 53 of 64 XP_016869755.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL5A1ENST00000371817.8 linkc.4176+35A>C intron_variant Intron 53 of 65 1 NM_000093.5 ENSP00000360882.3 P20908-1
COL5A1ENST00000371820.4 linkc.4176+35A>C intron_variant Intron 53 of 65 2 ENSP00000360885.4 P20908-2H7BY82

Frequencies

GnomAD3 genomes
AF:
0.466
AC:
70830
AN:
151884
Hom.:
17291
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.622
Gnomad AMI
AF:
0.393
Gnomad AMR
AF:
0.394
Gnomad ASJ
AF:
0.365
Gnomad EAS
AF:
0.458
Gnomad SAS
AF:
0.337
Gnomad FIN
AF:
0.364
Gnomad MID
AF:
0.453
Gnomad NFE
AF:
0.420
Gnomad OTH
AF:
0.453
GnomAD2 exomes
AF:
0.414
AC:
103242
AN:
249602
AF XY:
0.407
show subpopulations
Gnomad AFR exome
AF:
0.629
Gnomad AMR exome
AF:
0.370
Gnomad ASJ exome
AF:
0.374
Gnomad EAS exome
AF:
0.476
Gnomad FIN exome
AF:
0.358
Gnomad NFE exome
AF:
0.417
Gnomad OTH exome
AF:
0.411
GnomAD4 exome
AF:
0.415
AC:
598688
AN:
1441236
Hom.:
126586
Cov.:
29
AF XY:
0.414
AC XY:
297030
AN XY:
718112
show subpopulations
African (AFR)
AF:
0.631
AC:
20984
AN:
33236
American (AMR)
AF:
0.374
AC:
16674
AN:
44604
Ashkenazi Jewish (ASJ)
AF:
0.370
AC:
9603
AN:
25976
East Asian (EAS)
AF:
0.451
AC:
17854
AN:
39558
South Asian (SAS)
AF:
0.353
AC:
30263
AN:
85852
European-Finnish (FIN)
AF:
0.360
AC:
19117
AN:
53114
Middle Eastern (MID)
AF:
0.440
AC:
2413
AN:
5488
European-Non Finnish (NFE)
AF:
0.418
AC:
456636
AN:
1093680
Other (OTH)
AF:
0.421
AC:
25144
AN:
59728
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
15312
30624
45936
61248
76560
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13920
27840
41760
55680
69600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.466
AC:
70908
AN:
152002
Hom.:
17317
Cov.:
33
AF XY:
0.459
AC XY:
34124
AN XY:
74294
show subpopulations
African (AFR)
AF:
0.622
AC:
25780
AN:
41450
American (AMR)
AF:
0.394
AC:
6020
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.365
AC:
1265
AN:
3464
East Asian (EAS)
AF:
0.458
AC:
2361
AN:
5154
South Asian (SAS)
AF:
0.337
AC:
1625
AN:
4818
European-Finnish (FIN)
AF:
0.364
AC:
3847
AN:
10564
Middle Eastern (MID)
AF:
0.456
AC:
134
AN:
294
European-Non Finnish (NFE)
AF:
0.420
AC:
28566
AN:
67950
Other (OTH)
AF:
0.451
AC:
952
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1942
3883
5825
7766
9708
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
638
1276
1914
2552
3190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.449
Hom.:
9580
Bravo
AF:
0.479
Asia WGS
AF:
0.402
AC:
1400
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 23, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fibromuscular dysplasia, multifocal Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Ehlers-Danlos syndrome, classic type, 1 Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.41
DANN
Benign
0.40
PhyloP100
-3.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10776910; hg19: chr9-137708960; COSMIC: COSV65675377; API